Aurobindo Pharma gets US approval for ADHD drug

Aurobindo Pharma Ltd has received final approval from the United States health regulator for making generic version of Strattera capsules, used in treatment of Attention-Deficit/Hyperactivity Disorder.

The company has received approval to manufacture Atomoxetine capsules, which is the generic equivalent of Eli Lilly and Company’s Strattera capsules. The product will be launched immediately and will be manufactured at the company plant in Hyderabad.

Read More